Search
2 results for “heart health”
Topics
Health & Wellness
Ozempic vs. Mounjaro: New Heart Data From Europe's Biggest Diabetes Meeting Reignites the Rivalry
At EASD 2026 in Milan, Novo Nordisk presented real-world data from 636,525 adults linking escalated Ozempic 2 mg to 6% lower major cardiovascular event risk than switching to Mounjaro.
Meridian Newsroom30 Sept 20265 min read
Health & Wellness
Strokes Are Nearly Doubling Among Young Adults — and Experts Say It's a Wake-Up Call
A landmark Neurology study finds first-ever strokes among adults ages 20–54 rose from 33.9 to 62.2 per 100,000 over three decades — and while survival improved, more young adults are living with long-term disability.
Meridian Newsroom30 Sept 20266 min read